| Product Information |
|
| Registration Number |
DR-XY46172
|
| Generic Name |
Tofacitinib (as citrate)
|
| Brand Name |
Xeljanz
|
| Dosage Strength |
5mg
|
| Dosage Form |
Film-Coated Tablet
|
| Classification |
Prescription (Rx) Drug
|
| Pharmacologic Category |
Immunosuppressant (Janus-associated kinase (JAK)
inhibitor)
|
| Packaging |
Alu/Alu-PVC Blister Pack x 14's (Box of 56's)
|
| Manufacturer |
Pfizer Manufacturing Deutschland GmbH Betriebsstätte
|
| Country of Origin |
Germany
|
| Trader |
|
| Importer |
Pfizer, Inc.
|
| Distributor |
Pfizer, Inc.
|
| Application Type |
Initial (from Monitored Release)
|
| Issuance Date |
28 June 2024
|
| Expiry Date |
04 December 2027
|